Our (e)Books and (e)Journals

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.



Keystone Bio Announces Groundbreaking Data offering a More Complete Explanation of P. Gingivalis Toxic Virulence Factors

July 27, 2021 - St. Louis, MO, USA – Keystone Bio presents a detailed review of the literature shows incomplete human and animal model study design(s) to support the “local” gingipains AD brain model, but rather using new data and existing publication(s) – support a “peripheral” model of Pg blood-transported toxic virulence factors/OMVs as the major delivery mechanism into the brain.

July 27, 2021

Digital Pens Provide New Insight into Cognitive Testing Results

July 12, 2021 - Boston, MA, USA – During neuropsychological assessments, participants complete tasks designed to study memory and thinking. Based on their performance, the participants receive a score that researchers use to evaluate how well specific domains of their cognition are functioning. Consider, though, two participants who achieve the same score on one of these paper-and-pencil neuropsychological tests. One took 60 seconds to complete the task and was writing the entire time; the other spent three minutes, and alternated between writing answers and staring off into space. If researchers analyzed only the overall score of these two participants, would they be missing something important?

July 12, 2021

Latest Journal Citation Reports Shows Significant Impact Factor Increases for IOS Press Journals

July 28, 2021 - Amsterdam, NL – IOS Press, an independent international publisher of scientific, technical, and medical (STM) journals and books, is pleased to announce significant increases in the Journal Impact Factors (JIFs) of two of its flagship journals in neurogenerative diseases. The Journal of Parkinson’s Disease JIF has increased by 7.5% to 5.568, positioning it in the first quartile of Neuroscience journals with a ranking of 62 among 270 journals in that category. The Journal of Alzheimer’s Disease, the most highly cited journal devoted exclusively to this disease, rose by an impressive 14.4% to 4.472.

July 28, 2021

Digital Technology Driving Tangible Advancements in Parkinson’s Disease Research and Clinical Care

July 20, 2021 - Amsterdam, NL – Well over six million people globally have been diagnosed with Parkinson’s disease (PD), which has an enormous impact on the lives of patients, their families, and caregivers and is incurring mounting costs for society. This special supplement to the Journal of Parkinson’s Disease (JPD), guest-edited by noted experts Anat Mirelman, PhD, E. Ray Dorsey, MD, MBA, Patrik Brundin, MD, PhD, and Bastiaan R. Bloem, MD, PhD, reviews how digital technology is being used to reshape research and clinical care in PD.

July 20, 2021